Clinical Research Skills Development Program in Cell-Based Regenerative Medicine

被引:9
|
作者
Schulman, Ivonne Hernandez [1 ,2 ]
Suncion, Viky [1 ]
Karantalis, Vasileios [1 ]
Balkan, Wayne [1 ]
Hare, Joshua M. [1 ]
机构
[1] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA
[2] Univ Miami, Miller Sch Med, Div Nephrol & Hypertens, Miami, FL 33136 USA
关键词
MESENCHYMAL STEM-CELLS; TRANSENDOCARDIAL INJECTION; ISCHEMIC CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; TISSUE PERFUSION; THERAPY; NETWORK; DELIVERY; EUROPE; TRIALS;
D O I
10.5966/sctm.2014-0144
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Cell-based therapy aimed at restoring organ function is one of the most exciting and promising areas of medical research. However, a novel intervention like cell-based therapy requires physician education and training. An increasing number of physicians untrained in regenerative medicine are using cell-based therapy to treat patients for a wide variety of chronic illnesses. The current lack of training for physicians in this area combined with the sharply increasing practice of regenerative medicine is concerning for a number of reasons, namely potential harm to patients and avoidable conflicts between governmental regulatory agencies and physicians. Academic medical fellowship training programs are needed that specifically prepare physicians for treating patients with cell-based therapies for various organ systems and chronic diseases. The National Heart, Lung, and Blood Institute established the Cardiovascular Cell Therapy Network to design and conduct clinical trials that advance the field of cell-based therapy for patients with cardiovascular disease. As part of the network, a two-year Clinical Research Skills Development Program was supported at two centers with the goal of training early career investigators in cell-based clinical and translational research. In this review, we describe the implementation of this training program at our institution with the purpose of promoting the further development of academic fellowship programs in cell-based regenerative medicine.
引用
收藏
页码:118 / 122
页数:5
相关论文
共 50 条
  • [1] An FDA perspective on preclinical development of cell-based regenerative medicine products
    Alexander M Bailey
    Michael Mendicino
    Patrick Au
    Nature Biotechnology, 2014, 32 : 721 - 723
  • [2] An FDA perspective on preclinical development of cell-based regenerative medicine products
    Bailey, Alexander M.
    Mendicino, Michael
    Au, Patrick
    NATURE BIOTECHNOLOGY, 2014, 32 (08) : 721 - 723
  • [3] Cell-based therapy in lung regenerative medicine
    Yang, Jibing
    Jia, Zhenquan
    REGENERATIVE MEDICINE RESEARCH, 2014, 2
  • [4] Cell-based therapies for skeletal regenerative medicine
    Kwan, Matthew D.
    Slater, Bethany J.
    Wan, Derrick C.
    Longaker, Michael T.
    HUMAN MOLECULAR GENETICS, 2008, 17 : R93 - R98
  • [5] Cell-based regenerative medicine for renovascular disease
    Lerman, Lilach O.
    TRENDS IN MOLECULAR MEDICINE, 2021, 27 (09) : 882 - 894
  • [6] Regenerative medicine Clinical relevance, implications and limitations of the stem cell-based therapies
    Glinsky, Gennadi V.
    CELL CYCLE, 2008, 7 (21) : 3292 - 3293
  • [7] Regulating cell-based regenerative medicine: the challenges ahead
    Ali, Robin R.
    Hollander, Anthony P.
    Kemp, Paul
    Webster, Andrew
    Wilkins, Martin R.
    REGENERATIVE MEDICINE, 2014, 9 (01) : 81 - 87
  • [8] Stem Cell-Based Tissue Engineering for Regenerative Medicine
    Shi, Donglu
    Tatu, Rigwed
    Liu, Qing
    Hosseinkhani, Hossein
    NANO LIFE, 2014, 4 (02)
  • [9] Balancing Safety and Innovation for Cell-Based Regenerative Medicine
    Marks, Peter
    Gottlieb, Scott
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (10): : 954 - 959
  • [10] Engineered biomaterials in stem cell-based regenerative medicine
    Zhu, Fei
    Nie, Guangjun
    Liu, Changsheng
    LIFE MEDICINE, 2023, 2 (04):